Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MESDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC152274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FRMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAM2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM129A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAZ4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRAMEF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on